Tag: cancers
Curadev Pharma gets FDA nod for phase-1 study of its cancer...
The company has received US-FDA's 'Study May Proceed' letter for its Investigational New Drug Application of CRD3874, an IV-Administered STING Agonist for the treatment of advanced/metastatic solid cancers
Rising industrial growth leading to greater demand for radiotherapy devices
As radiotherapy continues to gain traction for being the most coveted treatment of a wide range of cancers, the global market for radiotherapy devices continues to expand exponentially
Avesthagen enters into strategic alliance with Wipro over genetic testing portfolio
The company has launched breakthrough genetic testing portfolio for cancers, neurological and rare diseases
ONCOCUR starts clinical assessment of nano-curcumin for oral cancer prevention
Pune based ONCOCUR has commenced the clinical study on nano-curcumin for oral cancer prevention at a leading hospital in Delhi NCR...........................
4677 generic medicine centres made functional by the end of 2018
As per the union government, unbranded generic medicines worth Rs 417 crores (MRP) have been sold through 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras that are functional in 35 States/UTs of the country...………..
iGenetic Diagnostics launches liquid biopsy test LiquidHALLMARK in India
iGenetic partners with Singapore-headquartered Lucence Diagnostics to make its liquid biopsy test LiquidHALLMARK available in India. The blood test spans multiple cancer-causing mutations and viruses to improve cancer diagnosis...………….
Heart disease, stroke among top killers in India
The prevalence of heart disease and stroke has increased by over 50% from 1990 to 2016 in India, with an increase observed in every state. Both contributed to 28·1% of total deaths in India in 2016, compared with 15·2% in 1990.........…......
Addressing cancer epidemic in India using power of genomics
While we understand the disease a lot better than we did a century ago with survival rates in some cancers as high as 90% now, we have challenges that are unique to our country, writes Dr Radhika Nair in the below column. Read details..............